{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 10.8, "exchange": "FRA", "shortName": "PHARMING GRP SP. ADRS", "longName": "Pharming Group N.V.", "messageBoardId": "finmb_32943", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "marketState": "REGULAR", "esgPopulated": false, "sharesOutstanding": 65634800, "bookValue": 3.12, "fiftyDayAverage": 10.475, "fiftyDayAverageChange": 0.3249998, "fiftyDayAverageChangePercent": 0.031026233, "twoHundredDayAverage": 10.6075, "twoHundredDayAverageChange": 0.19250011, "twoHundredDayAverageChangePercent": 0.018147549, "marketCap": 733140736, "forwardPE": -360.0, "priceToBook": 3.4615386, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1610607600000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683702902, "regularMarketDayHigh": 10.8, "regularMarketDayRange": "10.8 - 10.8", "regularMarketDayLow": 10.8, "regularMarketVolume": 41, "regularMarketPreviousClose": 10.8, "bid": 10.2, "ask": 11.1, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 10.8, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 4.8, "fiftyTwoWeekLowChangePercent": 0.8, "fiftyTwoWeekRange": "6.0 - 13.3", "fiftyTwoWeekHighChange": -2.5, "fiftyTwoWeekHighChangePercent": -0.18796992, "fiftyTwoWeekLow": 6.0, "fiftyTwoWeekHigh": 13.3, "trailingAnnualDividendRate": 0.0, "trailingPE": 54.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.2, "epsForward": -0.03, "symbol": "PHG.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Darwinweg 24", "city": "Leiden", "zip": "2333 CR", "country": "Netherlands", "phone": "31 71 524 7400", "fax": "31 71 524 7445", "website": "https://www.pharming.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.", "fullTimeEmployees": 332, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sijmen  de Vries M.B.A., M.D., MBA", "age": 63, "title": "Pres, CEO & Exec. Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 1176000, "fmt": "1.18M", "longFmt": "1,176,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeroen  Wakkerman", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mireille  Sanders M.Sc.", "age": 54, "title": "Chief Operations Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Susanne  Embleton", "title": "Investor Relations Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ruud  Van Outersterp", "age": 58, "title": "Chief Ethics & Compliance Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anurag  Relan M.D., MPH", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen  Toor", "age": 51, "title": "Chief Commercial Officer & GM Americas", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bruno M. L. Giannetti", "age": 70, "title": "Consultant", "yearBorn": 1952, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}